By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celator Pharmaceuticals, Inc. 

303B College Road East

Princeton  New Jersey  08540  U.S.A.
Phone: 609-243-0123 Fax: 609-243-0202


SEARCH JOBS








Company News
Celator Pharmaceuticals, Inc. To Present On Liposome Delivery Systems At 2014 American Association Of Pharmaceutical Scientists Annual Meeting 10/30/2014 10:53:22 AM
Celator Pharmaceuticals, Inc. Announces Completion Of Its Public Offering And The Exercise In Full Of Option To Purchase Additional Units Of Common Stock And Warrants To Purchase Common Stock 10/28/2014 9:54:08 AM
Celator Pharmaceuticals, Inc. Announces Phase 3 Clinical Study Of CPX-351 Achieved Target Enrollment In High Risk (Secondary) Acute Myeloid Leukemia 10/27/2014 7:37:39 AM
Celator Pharmaceuticals, Inc. Announces Pricing Of A $12.9 Million Public Offering Of Common Stock And Warrants To Purchase Common Stock 10/23/2014 7:28:23 AM
Celator Pharmaceuticals, Inc. Announces Public Offering Of Common Stock And Warrants To Purchase Common Stock 10/15/2014 9:07:01 AM
Celator Pharmaceuticals, Inc. To Present At Biocentury's 21st Annual Newsmakers In The Biotech Industry Conference 9/19/2014 7:19:17 AM
Celator Pharmaceuticals, Inc. To Ring The NASDAQ Stock Market Closing Bell On September 17, 2014 9/17/2014 10:12:56 AM
Celator Pharmaceuticals, Inc. To Ring The NASDAQ Stock Market Closing Bell 9/16/2014 1:24:12 PM
Celator Pharmaceuticals, Inc. Announces Publication Of Preclinical Data For CPX-351 In Acute Lymphoblastic Leukemia Models 9/15/2014 8:07:59 AM
Celator Pharmaceuticals, Inc. Announces Appointment Of Michael Dougherty As Chairman Of The Board 9/3/2014 7:22:35 AM
12345678910
//-->